Masaquel A - Search Results

1

Assessment of HER2 testing patterns, HER2+ disease, and the utilization of HER2-directed therapy in early breast cancer.

Stenehjem DD, Yoo M, Unni SK, Singhal M, Bauer H, Saverno K, Quah C, Masaquel A, Brixner DI. Stenehjem DD, et al. Among authors: masaquel a. Breast Cancer (Dove Med Press). 2014 Oct 29;6:169-77. doi: 10.2147/BCTT.S69416. eCollection 2014. Breast Cancer (Dove Med Press). 2014. PMID: 25378949 Free PMC article.

2

Economic burden related to chemotherapy-related adverse events in patients with metastatic breast cancer in an integrated health care system.

Rashid N, Koh HA, Baca HC, Lin KJ, Malecha SE, Masaquel A. Rashid N, et al. Among authors: masaquel a. Breast Cancer (Dove Med Press). 2016 Oct 4;8:173-181. doi: 10.2147/BCTT.S105618. eCollection 2016. Breast Cancer (Dove Med Press). 2016. PMID: 27785099 Free PMC article.

3

Comparison of treatment patterns and economic outcomes in metastatic breast cancer patients initiated on trastuzumab versus lapatinib: a retrospective analysis.

Guérin A, Lalla D, Gauthier G, Styles A, Wu EQ, Masaquel A, Brammer MG. Guérin A, et al. Among authors: masaquel a. Springerplus. 2014 May 8;3:236. doi: 10.1186/2193-1801-3-236. eCollection 2014. Springerplus. 2014. PMID: 24936383 Free PMC article.

4

The Lifetime Economic Burden of Inaccurate HER2 Testing: Estimating the Costs of False-Positive and False-Negative HER2 Test Results in US Patients with Early-Stage Breast Cancer.

Garrison LP Jr, Babigumira JB, Masaquel A, Wang BC, Lalla D, Brammer M. Garrison LP Jr, et al. Among authors: masaquel a. Value Health. 2015 Jun;18(4):541-6. doi: 10.1016/j.jval.2015.01.012. Epub 2015 May 16. Value Health. 2015. PMID: 26091608 Free article.

5

Estimated Life-Years Saved in Women with HER2-Positive Metastatic Breast Cancer Receiving First-Line Trastuzumab and Pertuzumab in the United States.

Danese MD, Masaquel A, Santos E, Brammer M, Lee A, Lalla D. Danese MD, et al. Among authors: masaquel a. Value Health. 2015 Sep;18(6):876-83. doi: 10.1016/j.jval.2015.06.003. Epub 2015 Aug 13. Value Health. 2015. PMID: 26409616 Free article.

6

Delay in initiation of adjuvant trastuzumab therapy leads to decreased overall survival and relapse-free survival in patients with HER2-positive non-metastatic breast cancer.

Gallagher CM, More K, Kamath T, Masaquel A, Guerin A, Ionescu-Ittu R, Gauthier-Loiselle M, Nitulescu R, Sicignano N, Butts E, Wu EQ, Barnett B. Gallagher CM, et al. Among authors: masaquel a. Breast Cancer Res Treat. 2016 May;157(1):145-56. doi: 10.1007/s10549-016-3790-3. Epub 2016 Apr 23. Breast Cancer Res Treat. 2016. PMID: 27107569 Free PMC article.

7

Maintenance rituximab in Veterans with follicular lymphoma.

Halwani AS, Rasmussen KM, Patil V, Morreall D, Li C, Yong C, Burningham Z, Dawson K, Masaquel A, Henderson K, DeLong-Sieg E, Sauer BC. Halwani AS, et al. Among authors: masaquel a. Cancer Med. 2020 Oct;9(20):7537-7547. doi: 10.1002/cam4.3420. Epub 2020 Aug 28. Cancer Med. 2020. PMID: 32860335 Free PMC article.

8

Identification and cost of adverse events in metastatic breast cancer in taxane and capecitabine based regimens.

Hansen RN, Ramsey SD, Lalla D, Masaquel A, Kamath T, Brammer M, Hurvitz SA, Sullivan SD. Hansen RN, et al. Among authors: masaquel a. Springerplus. 2014 May 21;3:259. doi: 10.1186/2193-1801-3-259. eCollection 2014. Springerplus. 2014. PMID: 24926422 Free PMC article.

9

Overall Survival in Patients with HER2+ Early Stage Breast Cancer Patients Treated with Trastuzumab in the US Department of Defense Practice Setting.

Gallagher CM, More K, Masaquel AS, Kamath T, Guerin A, Ionescu-Ittu R, Gauthier-Loiselle M, Nitulescu R, Sicignano N, Barnett B, Wu EQ. Gallagher CM, et al. Among authors: masaquel as. Value Health. 2014 Nov;17(7):A615. doi: 10.1016/j.jval.2014.08.2164. Epub 2014 Oct 26. Value Health. 2014. PMID: 27202155 Free article. No abstract available.

10

The economic burden of end-of-life care in metastatic breast cancer.

Bramley T, Antao V, Lunacsek O, Hennenfent K, Masaquel A. Bramley T, et al. Among authors: masaquel a. J Med Econ. 2016 Nov;19(11):1075-1080. doi: 10.1080/13696998.2016.1197130. Epub 2016 Jun 17. J Med Econ. 2016. PMID: 27248201 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters